M. Michelle Berrey - President, R&D and CMO at Intercept Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, R&D and CMO
Stock Symbol
ICPT
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by M. Michelle Berrey since 9/17/2023

Holdings reported by M. Michelle Berrey for Intercept Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $19.00 Nov 8, 2023 Direct
Option to Purchase Common Stock 0 Nov 8, 2023 Direct Common Stock

Transactions reported by M. Michelle Berrey for Intercept Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.